Monopar Therapeutics Inc (MNPR)
Healthcare
Biotechnology
108.40 $
-5.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Monopar Therapeutics Inc (MNPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -3.5 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.1 | -1.9 | -1.5 | -1.7 | -1.7 | -1.1 | -2.0 | -5.7 | -1.1 | -2.1 | -3.4 | -3.5 | -10 | |
| 0.5 | 0.5 | 0.5 | 0.3 | 0.3 | 0.2 | 0.3 | 1.4 | 1.3 | 1.1 | 1.1 | 1.7 | 5.2 | |
| 0.5 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.4 | -0.5 | -0.2 | -0.3 | -0.3 | 0.0 | 4.1 | -4.4 | 0.1 | 0.2 | 1.4 | -0.5 | 1.3 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 3.0 | 0.0 | 3.0 | -1.0 | 0.0 | 1.0 | -14 | -0.3 | 1.2 | -2.1 | -62 | -5.6 | -69 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | -35 | 0.0 | -0.2 | – | |
| 0.6 | 0.2 | 0.3 | 3.2 | 0.0 | 0.0 | 56 | -0.1 | -0.3 | 92 | -0.4 | -0.2 | 91 | |
| 1.5 | -1.7 | 1.8 | 0.5 | -1.7 | -0.1 | 40 | -6.1 | -0.2 | 88 | -66 | -9.3 | 13 | |
| -2.1 | -1.9 | -1.5 | -1.7 | -1.7 | -1.1 | -2.0 | -5.7 | -1.1 | -2.1 | -3.4 | -3.5 | -10 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.